Publication Cover
Materials Technology
Advanced Performance Materials
Volume 34, 2019 - Issue 8
160
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

In vitro haemocompatibility and cytocompatibility evaluation of silver thin film-deposited heart valve prosthesis material

, , , &
Pages 471-479 | Received 03 May 2018, Accepted 21 Jan 2019, Published online: 18 Feb 2019

References

  • Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324(1):573–579.
  • Tracy Tina Angelina J, Ganesan S, Panicker TMR, et al. Pulsed laser deposition of silver nanoparticles on prosthetic heart valve material to prevent bacterial infection. Mater Technol Adv Perform Mater. 2017;32(3):148–155.
  • Horstkotte D, Burckhardt D. Prosthetic valve thrombosis. J Heart Valve Dis. 1995;4(2):141–153.
  • Murat B, Ibrahim A, Ozcan B, et al. Treatment of prosthetic valve thrombosis: current evidence and future directions. J Clin Med Res. 2015;7(12):932–936.
  • Seeburger J, Groesdonk H, Borger MA, et al. Quadruple valve replacement for acute endocarditis. J Thorac Cardiovasc Surg. 2009;137(6):1564–1565.
  • Oezkan M, Kaymaz C, Kirma C. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J Am Coll Cardiol. 2000;35(7):1881–1889.
  • Gohlke Barwolf C. Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery. Heart. 2000;84(5):715–721.
  • Johnston HJ, Hutchison G, Christensen FM, et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4):328–346.
  • Ji JH, Jung J, Kim SS. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2007;19(10):857–871.
  • Kim KJ, Sung WS, Suh BK, et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals. 2009;22(2):235–242.
  • DeJong WH, Vander Ven LTM, Sleijffers A. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials. 2013;34(33):8333–8343.
  • Haji B, Faheem M, Kamal N, et al. Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J. 2016;20(1):1–11.
  • Maggie N, Tillquist, Thomas M Maddox. Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement. Patient Prefer Adherence. 2011;5(1):91–99.
  • VanGeldorp MW, Jamieson E, Kappetein AP. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137(4):881–886.
  • Richard M, Rigolin VH. 2017 focused update for management of patients with valvular heart disease: summary of new recommendations. J Am Heart Assoc. 2018;7:117.007.
  • Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003;41:893–904.
  • Debapriya B, Haren B, Bharat G, et al. Silver nano particles prevent platelet adhesion on immobilized fibrinogen. Indian J Clin Biochem. 2012;27(2):164–170.
  • Krzysztof Tomaszewski A, Marek Radomski W and Maria Santos Martinez J. Nanodiagnostics, nanopharmacology and nanotoxicology of platelet–vessel wall interactions. Nanomedicine. 2015;10(9):1451–1475.
  • Jiang W, Kim BYS, Rutka JT, et al. Nanoparticle-mediated cellular response is size- dependent. Nat Nanotechnol. 2008;3(1):145–150.
  • Kemp MM, Kumar A, Mousa S, et al. Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities. Biomacromolecules. 2009;10(3):589–595.
  • Muniyandi J, Senthilkumar V, Kevin John PA, et al. Antimicrobial and anticoagulation activity of silver nanoparticles synthesized from the culture supernatant of Pseudomonas aeruginosa. J Ind Eng Chem. 2013;19(4):1299–1303.
  • Niloofar A, Cian V, Stephanie Bogan L, et al. Gold nanoparticle interactions in human blood: a model evaluation. Nanomed. 2017;13(4):1531–1542.
  • Ilinskaya AN, Dobrovolskaia MA. Nanoparticles and the blood coagulation system- Part I: benefits of nanotechnology. Nanomedicine. 2013;8(5):773–784.
  • Ragaseema VM, Unnikrishnan S, Kalliyana Krishnan V, et al. The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomaterials. 2012;33(11):3083–3092.
  • Kalishwaralal K, Deepak V, RamKumar Pandian S, et al. Biosynthesis of silver and gold nanoparticles using Brevibacterium casei. Colloids Surf B. 2010;77(2):257–262.
  • Shrivastava S, Bera T, Singh SK, et al. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano. 2009;3(6):1357–1364.
  • Martinez-Gutierrez F, Olive PL, Banuelos A. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomed. 2010;6(5):681–688.
  • Hsin YH, Chen CF, Huang S, et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008;179(3):130–139.
  • Shin SH, Ye MK, Kim HS, et al. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol. 2007;7(13):1813–1818.
  • Tang HQ, Feng HJ, Zheng JH, et al. A study on antibacterial properties of Ag+-implanted pyrolytic carbon. Surf Coat Technol. 2007;201(1):5633–5636.
  • Zheng Z, Yin W, Zara JN. The use of BMP-2 coupled-nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials. 2010;31(35):9293–9300.
  • Masse A, Bruno A, Bosetti M, et al. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;53(5):600–604.
  • Pulit J, Banach M, Szczygłowska R, et al. Nanosilver against fungi: silver nanoparticles as an effective biocidal factor. Acta Biochimica Polonica. 2013;60(4):795–798.
  • Yoon KY, Byeon JH, Park JH, et al. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ. 2007;373(2):572–575.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.